Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Allocated Share-based Compensation Expense | $ 8,606 | $ 9,372 | $ 18,558 | $ 18,330 |
| Cost of revenue [Member] | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Allocated Share-based Compensation Expense | 383 | 360 | 763 | 660 |
| Research, development and clinical trials expenses [Member] | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Allocated Share-based Compensation Expense | 1,065 | 1,189 | 2,535 | 2,505 |
| Selling, general and administrative expenses [Member] | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Allocated Share-based Compensation Expense | $ 7,158 | $ 7,823 | $ 15,260 | $ 15,165 |